ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 986

Do Death Certificates Underestimate the Burden of Rare Diseases: The Example of Systemic Lupus Erythematosus Mortality in Sweden

Titilola Falasinnu1, Marios Rossides2, Yashaar Chaichian3 and Julia F Simard4, 1Health Research and Policy, Stanford University, Stanford, CA, 2Medicine Solna, Clinical Epidemiology Unit, Karolinska Institutet, Stockholm, Sweden, 3Medicine, Immunology & Rheumatology Division, Stanford School of Medicine, Stanford, CA, 4Division of Epidemiology, Health Research and Policy Department, Stanford School of Medicine, Stanford, CA

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: big data and death, SLE

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 6, 2017

Title: Epidemiology and Public Health Poster II: Rheumatic Diseases Other than Rheumatoid Arthritis

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Routine data sources such as death certificates are used to estimate the burden or cost of disease in a population. However, mortality due to rare diseases, e.g., systemic lupus erythematosus (SLE), that are significant sources of premature mortality, is often ignored in mortality reports. The objective of this study was to determine the completeness of SLE mention in the death register in Sweden and patterns of completeness by demographic factors.

Methods: A Swedish population-based cohort of individuals with prevalent SLE (the Swedish Lupus Linkage [SLINK]; 2001-2013) was linked to the Cause of Death Register. All death records from subjects known to be deceased in the cohort were reviewed and information regarding patient demographics (i.e., sex, age, region, place, and year of death) and causes of death were extracted. Odds ratios (OR) and 95% confidence intervals (95% CI) for the absence of SLE on death certificates were estimated using a multivariable-adjusted logistic model. We also estimated the degree of over- or underestimated SLE mortality using the comparability ratio.

Results: Approximately 59% of decedents with SLE had SLE absent from their death certificates (n=1,802). The majority of deceased individuals were aged 60-79 years at death (52%), female (81%), and born in Nordic countries (96%). In the adjusted model, increasing age was associated with SLE being absent from death certificates among those in the established cohort. Decedents 60-79 years old at death were approximately 2.5 times as likely to have SLE missing from their death certificates compared with those <40 years (OR: 2.48, 95% CI: 1.34-4.58). Having renal failure listed on the death certificate decreased the likelihood of SLE being absent (OR: 0.55, 95% CI: 0.41-0.73), while cancer increased this likelihood (OR: 2.35, 95% CI: 1.83-3.02). Death certificate data underestimated SLE mortality by 59% (comparability ratio 0.41 [95% 0.38-0.43]).

Conclusion: SLE is greatly underreported as a cause of death on death certificates thereby underestimating the burden of this disease. This may be due to ambiguity and disparate practices concerning the recording of comorbidities in death certificates. Inadequate attention may be devoted to the contribution of lupus to cancer secondary to systemic inflammation compared to lupus mortality related to direct organ involvement.


Disclosure: T. Falasinnu, None; M. Rossides, None; Y. Chaichian, None; J. F. Simard, None.

To cite this abstract in AMA style:

Falasinnu T, Rossides M, Chaichian Y, Simard JF. Do Death Certificates Underestimate the Burden of Rare Diseases: The Example of Systemic Lupus Erythematosus Mortality in Sweden [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/do-death-certificates-underestimate-the-burden-of-rare-diseases-the-example-of-systemic-lupus-erythematosus-mortality-in-sweden/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/do-death-certificates-underestimate-the-burden-of-rare-diseases-the-example-of-systemic-lupus-erythematosus-mortality-in-sweden/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology